Impact of COVID-19 on Clinical Care and Research in Cancer Imaging: Where We Are Now.
作者信息
Luker Gary D, Boettcher Adeline N
机构信息
Department of Radiology, University of Michigan, Ann Arbor, Michigan.
出版信息
Radiol Imaging Cancer. 2021 Jan 22;3(1):e210003. doi: 10.1148/rycan.2021210003. eCollection 2021 Jan.
Abstract
摘要
相似文献
1
Impact of COVID-19 on Clinical Care and Research in Cancer Imaging: Where We Are Now.
Radiol Imaging Cancer. 2021 Jan 22;3(1):e210003. doi: 10.1148/rycan.2021210003. eCollection 2021 Jan.
2
Editorial: immunosuppression and SARS-CoV-2 vaccination-where do we stand?
Aliment Pharmacol Ther. 2023 Jan;57(1):163-164. doi: 10.1111/apt.17276.
3
The dangers of immunosuppression and solid organ transplant in the SARS-CoV-2 pandemic era.
Pol Arch Intern Med. 2022 Feb 28;132(2). doi: 10.20452/pamw.16212.
4
Cancer or COVID-19? A Review of Recommendations for COVID-19 Vaccination in Cancer Patients.
Curr Treat Options Oncol. 2021 Sep 13;22(10):95. doi: 10.1007/s11864-021-00903-7.
5
Prevalence of SARS-CoV-2-IgG Antibodies in Children with CKD or Immunosuppression.
Clin J Am Soc Nephrol. 2021 Jul;16(7):1097-1099. doi: 10.2215/CJN.00330121. Epub 2021 Jun 7.
6
COVID-19 in an adolescent with aplastic anemia undergoing immunosuppressive therapy: A case report and details of antibody testing for SARS-CoV-2.
Pediatr Blood Cancer. 2022 Feb;69(2):e29332. doi: 10.1002/pbc.29332. Epub 2021 Sep 5.
7
Rapamycin and inulin for booster vaccine response stimulation (RIVASTIM)-rapamycin: study protocol for a randomised, controlled trial of immunosuppression modification with rapamycin to improve SARS-CoV-2 vaccine response in kidney transplant recipients.
Trials. 2022 Sep 15;23(1):780. doi: 10.1186/s13063-022-06634-w.
8
Transplant Immunosuppression Management and COVID-19.
Exp Clin Transplant. 2022 Jul;20(7):706-707. doi: 10.6002/ect.2020.0179. Epub 2020 Sep 17.
9
Survey on the impact of COVID19 in patients on immunosuppression for ocular and orbital inflammatory disorders.
Eur J Ophthalmol. 2022 Jan;32(1):NP280-NP282. doi: 10.1177/11206721211008039. Epub 2021 Apr 8.
10
[Repeatedly re-detectable positive for SARS-CoV-2 by RT-PCR in the immunosuppressive therapy of a patient: a case report and literature review].
Zhonghua Xue Ye Xue Za Zhi. 2023 Jun 14;44(6):520-522. doi: 10.3760/cma.j.issn.0253-2727.2023.06.016.
引用本文的文献
1
Trends in oncological imaging during the COVID-19 pandemic through the vaccination era.
Cancer Med. 2023 Apr;12(8):9902-9911. doi: 10.1002/cam4.5678. Epub 2023 Feb 12.
2
Institutional Strategies to Maintain and Grow Imaging Research During the COVID-19 Pandemic.
Acad Radiol. 2023 Apr;30(4):631-639. doi: 10.1016/j.acra.2022.12.045. Epub 2023 Jan 6.
3
Validation of a highly accelerated post-contrast wave-controlled aliasing in parallel imaging (CAIPI) 3D-T1 MPRAGE compared to standard 3D-T1 MPRAGE for detection of intracranial enhancing lesions on 3-T MRI.
Eur Radiol. 2023 Apr;33(4):2905-2915. doi: 10.1007/s00330-022-09265-6. Epub 2022 Dec 2.
4
Impact of the COVID-19 Pandemic on Breast Cancer Management in Portugal: A Cross-Sectional Survey-Based Study of Medical Oncologists.
Oncol Ther. 2022 Jun;10(1):225-240. doi: 10.1007/s40487-022-00191-7. Epub 2022 Mar 21.
5
Haematological malignancies implications during the times of the COVID-19 pandemic.
Oncol Lett. 2021 Dec;22(6):856. doi: 10.3892/ol.2021.13117. Epub 2021 Oct 29.
6
Imaging in the COVID-19 era: Lessons learned during a pandemic.
World J Radiol. 2021 Jun 28;13(6):192-222. doi: 10.4329/wjr.v13.i6.192.
7
Get comfortable with being uncomfortable: Experiences from diagnostic radiographers a year into the COVID-19 pandemic.
J Med Imaging Radiat Sci. 2021 Sep;52(3):332-339. doi: 10.1016/j.jmir.2021.05.003. Epub 2021 May 14.
本文引用的文献
1
Transitioning to a New Normal after COVID-19: Preparing to Get Back on Track for Cancer Imaging.
Radiol Imaging Cancer. 2020 Apr 15;2(3):e204011. doi: 10.1148/rycan.2020204011. eCollection 2020 May.
2
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
3
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.
N Engl J Med. 2021 Jan 7;384(1):80-82. doi: 10.1056/NEJMc2032195. Epub 2020 Dec 3.
4
Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer.
N Engl J Med. 2020 Dec 24;383(26):2586-2588. doi: 10.1056/NEJMc2031670. Epub 2020 Dec 1.
5
COVID-19 and cancer.
Science. 2020 Jun 19;368(6497):1290. doi: 10.1126/science.abd3377.
6
Impact of the COVID-19 crisis on imaging in oncological trials.
Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2054-2058. doi: 10.1007/s00259-020-04910-y.
Zotero 插件